Late Breaking News II
Saturday, October 13, 2012, 08:45 – 09:00
Chronic Cerebro-Spinal Venous Insufficiency (CCSVI) and global venous haemodynamics in multiple sclerosis: the CoSMo study
(it: L’insufficienza venosa cronica cerebro spinale (CCSVI) e l’emodinamica venosa globale nella sclerosi multipla: lo studio CoSMo)
G. Comi, M.A. Battaglia, A. Bertolotto, M. Del Sette, A. Ghezzi, G. Malferrari, M. Salvetti, M. Sormani, E. Stolz, L. Tesio, G.L. Mancardi on behalf of the CoSMo study group
Text not available (it: testo non disponibile).
Dr. Battaglia has no conflicts of interest to declare. Dr A. Bertolotto has been on steering committees in clinical trials sponsored by Biogen Idec, Roche, and has received speaker honoraria from Biogen Idec, Merck Serono, TEVA, Bayer Schering, Sanofi-aventis, and Novartis; and has received research support from Biogen Idec, Bayer Schering, Merck Serono, Sanofi-Aventis, from the Italian Multiple Sclerosis Society, and the European Union Sixth Framework Programme. Dr. Comi has received consulting fees for participating on advisory boards from Novartis, Teva Pharmaceutical Ind. Ltd., Sanofi-Aventis, Merck Serono, and Bayer Schering; lecture fees from Novartis, Teva Pharmaceutical Ind. Ltd., Sanofi-Aventis, Merck Serono, Biogen Dompè, Bayer Schering and Serono Symposia International Foundation. He is member of the Board of the Italian MS Foundation. Dr. M. Del Sette has no conflicts of interest to declare. Dr A. Ghezzi received honoraria for speaking from Bayer-Schering, Biogen-Dompè, Merck-Serono, Novartis, Sanofi-Aventis and Allergan, for consultancy from Actelion, Merck-Serono, Teva and Novartis, received support for participation to National and International Congresses from Bayer-Schering, Biogen-Dompè, Merck- Serono, Novartis and Sanofi-Aventis. Dr G. Malferrari has no conflicts of interest to declare. Dr. GL Mancardi received honoraria for lecturing, travel expenses for attending meetings, and financial support for research from Bayer Schering, Biogen Idec, Sanofi-Aventis, Novartis and Merck Serono Pharmaceuticals. He is member of the Board of the Italian MS Foundation. Dr. M Salvetti declares grant support from Bayer-Schering, Merck-Serono, Sanofi-Aventis and Biogen Idec. Dr. MP Sormani has received consulting fee or honoraria from Biogen Idec, Merck Serono, Actelion, Synthon and TEVA. Dr. E. Stolz has no conflicts of interest to declare. Dr. L. Tesio is member of the Board of the Italian MS Foundation.
